Crown Advisors Management, Inc. Acadia Pharmaceuticals Inc Transaction History

Crown Advisors Management, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2023 May 09, 2023	BUY	$16.32 - $20.92 $489,600 - $627,600	30,000 New	30,000 $564,000
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $423,300 - $548,100	30,000 New	30,000 $490,000

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Crown Advisors Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Crown Advisors Management, Inc. with notifications on news.